AVITI
LIVE

Serial Number

90981599

Owner

Element Biosciences, Inc.

Attorney

Samantha C. Markley

First Use Date

Mar 14, 2023

Filing Date

Jun 11, 2021

Add to watchlist:

No watchlists yet
View on USPTO

AVITI Trademark

Serial Number: 90981599 • Registration: 8103398

AVITI is a trademark filed by Element Biosciences, Inc. on June 11, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Element Biosciences, Inc. (38 trademarks)

9880 Campus Point Drive, Suite 210
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

June 11, 2021

Registration Date

January 13, 2026

First Use Anywhere

March 14, 2023

First Use in Commerce

March 14, 2023

Published for Opposition

October 18, 2022

Goods & Services

Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers

Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes

Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 13, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 13, 2026 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 7, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 7, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 7, 2026 REAP
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 22, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 22, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 15, 2025 SUPC
DIVISIONAL PROCESSING COMPLETE
Dec 15, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 15, 2025 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 10, 2025 AITU
USE AMENDMENT FILED
Oct 24, 2025 IUAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 24, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 24, 2025 REAP
DIVISIONAL REQUEST RECEIVED
Jun 12, 2025 DRRR
TEAS STATEMENT OF USE RECEIVED
Jun 12, 2025 EISU
TEAS REQUEST TO DIVIDE RECEIVED
Jun 12, 2025 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Dec 7, 2024 EX4G
SOU EXTENSION 4 FILED
Dec 7, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 6, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 10, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 10, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 10, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 2, 2023 EXRA
SOU EXTENSION 2 GRANTED
Nov 30, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 30, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 30, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 8, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 6, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 6, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 6, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 13, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 18, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 7, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2021 NWOS
NEW APPLICATION ENTERED
Jun 15, 2021 NWAP